Study of AZLI in a CAT Regimen of Inhaled Antibiotics for Chronic Pulmonary Pseudomonas Aeruginosa


Clinical Trial

Offered by: Nemours
Location: Orlando, FL

Trial Name

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection in Subjects with Cystic Fibrosis

What is the trial about?

A study in adult and pediatric subjects with cystic fibrosis (CF) and pulmonary Pseudomonas aeruginosa (PA) infection.

Who can participate?

Subjects ≥ 6 years of age with CF and chronic pulmonary PA infection, Males or females ≥ 6 years of age.

What is involved?

Length of study is about 7 months, not including the screening period. Tests and procedures include: CF Questionnaire; physical exam; sputum sample/throat swab; urine pregnancy test; spirometry; bronchodilator.

Contact Nemours Clinical Trials

Trial Name: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection in Subjects with Cystic Fibrosis

Contact Information

(800) 354-5690
clinicaltrials@nemours.org